A ‘can be used’ recommendation is a positive recommendation and means that there is enough evidence to show that a technology provides benefits and value for money, so it can be used routinely across ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

For information, the company have advised that they are no longer pursuing a Marketing Authorisation Application from the Medicines and Healthcare products Regulatory Agency (MHRA) for this indication ...

A list of downloadable documents created during development.

Proposed changes to appeal period for technology appraisal and highly specialised technologies appeals Methods / process manual consultation NICE process and methods 16 February 2025 Spesolimab for ...

There is a simple discount patient access scheme for vadadustat. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact enquiries@medice ...

The 4 technology appraisal committees are standing advisory committees of NICE. This topic was considered by committee B. Committee members are asked to declare any interests in the vadadustat being ...

The evaluation committee considered evidence submitted by MEDICE, a review of this submission by the external assessment group (EAG), and responses from stakeholders. See the committee papers for full ...

Tools to help you put the guidance into practice.